Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin^®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult-to-Treat Erectile Dysfunction: A Case Series

Registered pharmacological treatments are insufficiently effective for erectile dysfunction (ED) in around 30% of affected men. Intracavernosal injection (ICI) of ona- and abobotulinumtoxinA can reduce ED in insufficient responders. We aimed to assess the safety and effectiveness of incobotulinumtox...

Full description

Bibliographic Details

Published in:	Toxins
Main Authors:	Francois Giuliano, Pierre Denys, Charles Joussain
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Subjects:	botulinum toxin A combination therapy non-responders erectile dysfunction pharmacology
Online Access:	https://www.mdpi.com/2072-6651/14/4/286